[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Embryonic Stem Cell Market Research Report Forecast 2017-2021

March 2017 | 115 pages | ID: UE67A138681EN
S&P Consulting

US$ 2,960.00 US$ 3,700.00 -20 %

E-mail Delivery (PDF), E-mail Delivery (Word), E-mail Delivery (Excel), E-mail Delivery (PowerPoint)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The United States Embryonic Stem Cell Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Embryonic Stem Cell industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Embryonic Stem Cell market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs
The Major players reported in the market include:
  • Neuralstem
  • NeuroNova AB
  • NeuroGeneration
  • StemCells
  • ReNeuron Limited
  • Asterias Biotherapeutics
  • Thermo Fisher Scientific
  • STEMCELL Technologies
  • Axol Bio
United States Embryonic Stem Cell Market: Product Segment Analysis
  • Type 1
  • Type 2
  • Type 3
United States Embryonic Stem Cell Market: Application Segment Analysis
  • Medical care
  • Hospital
  • Laboratory
Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
CHAPTER 1 EMBRYONIC STEM CELL MARKET OVERVIEW

1.1 Product Overview and Scope of Embryonic Stem Cell
1.2 Embryonic Stem Cell Market Segmentation by Type
  1.2.1 United States Production Market Share of Embryonic Stem Cell by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Embryonic Stem Cell Market Segmentation by Application
  1.3.1 Embryonic Stem Cell Consumption Market Share by Application in 2015
  1.3.2 Medical care
  1.3.3 Hospital
  1.3.4 Laboratory
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Embryonic Stem Cell (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON EMBRYONIC STEM CELL INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES EMBRYONIC STEM CELL MARKET COMPETITION BY MANUFACTURERS

3.1 United States Embryonic Stem Cell Production and Share by Manufacturers (2015 and 2016)
3.2 United States Embryonic Stem Cell Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Embryonic Stem Cell Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Embryonic Stem Cell Manufacturing Base Distribution, Production Area and Product Type
3.5 Embryonic Stem Cell Market Competitive Situation and Trends
  3.5.1 Embryonic Stem Cell Market Concentration Rate
  3.5.2 Embryonic Stem Cell Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES EMBRYONIC STEM CELL PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Embryonic Stem Cell Production and Market Share by Type (2012-2017)
4.2 United States Embryonic Stem Cell Revenue and Market Share by Type (2012-2017)
4.3 United States Embryonic Stem Cell Price by Type (2012-2017)
4.4 United States Embryonic Stem Cell Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES EMBRYONIC STEM CELL MARKET ANALYSIS BY APPLICATION

5.1 United States Embryonic Stem Cell Consumption and Market Share by Application (2012-2017)
5.2 United States Embryonic Stem Cell Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES EMBRYONIC STEM CELL MANUFACTURERS ANALYSIS

6.1 Neuralstem
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 NeuroNova AB
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 NeuroGeneration
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 StemCells
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 ReNeuron Limited
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 Asterias Biotherapeutics
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 Thermo Fisher Scientific
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 STEMCELL Technologies
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 Axol Bio
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 EMBRYONIC STEM CELL MANUFACTURING COST ANALYSIS

7.1 Embryonic Stem Cell Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Embryonic Stem Cell

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Embryonic Stem Cell Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Embryonic Stem Cell Major Manufacturers in 2015
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES EMBRYONIC STEM CELL MARKET FORECAST (2017-2021)

11.1 United States Embryonic Stem Cell Production, Revenue Forecast (2017-2021)
11.2 United States Embryonic Stem Cell Production, Consumption Forecast by Regions (2017-2021)
11.3 United States Embryonic Stem Cell Production Forecast by Type (2017-2021)
11.4 United States Embryonic Stem Cell Consumption Forecast by Application (2017-2021)
11.5 Embryonic Stem Cell Price Forecast (2017-2021)

CHAPTER 12 APPENDIX

LIST OF TABLES AND FIGURES
Figure Picture of Embryonic Stem Cell
Table Classification of Embryonic Stem Cell
Figure United States Sales Market Share of Embryonic Stem Cell by Type in 2015
Table Application of Embryonic Stem Cell
Figure United States Sales Market Share of Embryonic Stem Cell by Application in 2015
Figure United States Embryonic Stem Cell Sales and Growth Rate (2011-2021)
Figure United States Embryonic Stem Cell Revenue and Growth Rate (2011-2021)
Table United States Embryonic Stem Cell Sales of Key Manufacturers (2015 and 2016)
Table United States Embryonic Stem Cell Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Embryonic Stem Cell Sales Share by Manufacturers
Figure 2016 Embryonic Stem Cell Sales Share by Manufacturers
Table United States Embryonic Stem Cell Revenue by Manufacturers (2015 and 2016)
Table United States Embryonic Stem Cell Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Embryonic Stem Cell Revenue Share by Manufacturers
Table 2016 United States Embryonic Stem Cell Revenue Share by Manufacturers
Table United States Market Embryonic Stem Cell Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Embryonic Stem Cell Average Price of Key Manufacturers in 2015
Figure Embryonic Stem Cell Market Share of Top 3 Manufacturers
Figure Embryonic Stem Cell Market Share of Top 5 Manufacturers
Table United States Embryonic Stem Cell Sales by Type (2012-2017)
Table United States Embryonic Stem Cell Sales Share by Type (2012-2017)
Figure United States Embryonic Stem Cell Sales Market Share by Type in 2015
Table United States Embryonic Stem Cell Revenue and Market Share by Type (2012-2017)
Table United States Embryonic Stem Cell Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Embryonic Stem Cell by Type (2012-2017)
Table United States Embryonic Stem Cell Price by Type (2012-2017)
Figure United States Embryonic Stem Cell Sales Growth Rate by Type (2012-2017)
Table United States Embryonic Stem Cell Sales by Application (2012-2017)
Table United States Embryonic Stem Cell Sales Market Share by Application (2012-2017)
Figure United States Embryonic Stem Cell Sales Market Share by Application in 2015
Table United States Embryonic Stem Cell Sales Growth Rate by Application (2012-2017)
Figure United States Embryonic Stem Cell Sales Growth Rate by Application (2012-2017)
Table Neuralstem Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Neuralstem Embryonic Stem Cell Production, Revenue, Price and Gross Margin (2012-2017)
Table Neuralstem Embryonic Stem Cell Market Share (2012-2017)
Table NeuroNova AB Basic Information, Manufacturing Base, Production Area and Its Competitors
Table NeuroNova AB Embryonic Stem Cell Production, Revenue, Price and Gross Margin (2012-2017)
Table NeuroNova AB Embryonic Stem Cell Market Share (2012-2017)
Table NeuroGeneration Basic Information, Manufacturing Base, Production Area and Its Competitors
Table NeuroGeneration Embryonic Stem Cell Production, Revenue, Price and Gross Margin (2012-2017)
Table NeuroGeneration Embryonic Stem Cell Market Share (2012-2017)
Table StemCells Basic Information, Manufacturing Base, Production Area and Its Competitors
Table StemCells Embryonic Stem Cell Production, Revenue, Price and Gross Margin (2012-2017)
Table StemCells Embryonic Stem Cell Market Share (2012-2017)
Table ReNeuron Limited Basic Information, Manufacturing Base, Production Area and Its Competitors
Table ReNeuron Limited Embryonic Stem Cell Production, Revenue, Price and Gross Margin (2012-2017)
Table ReNeuron Limited Embryonic Stem Cell Market Share (2012-2017)
Table Asterias Biotherapeutics Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Asterias Biotherapeutics Embryonic Stem Cell Production, Revenue, Price and Gross Margin (2012-2017)
Table Asterias Biotherapeutics Embryonic Stem Cell Market Share (2012-2017)
Table Thermo Fisher Scientific Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Thermo Fisher Scientific Embryonic Stem Cell Production, Revenue, Price and Gross Margin (2012-2017)
Table Thermo Fisher Scientific Embryonic Stem Cell Market Share (2012-2017)
Table STEMCELL Technologies Basic Information, Manufacturing Base, Production Area and Its Competitors
Table STEMCELL Technologies Embryonic Stem Cell Production, Revenue, Price and Gross Margin (2012-2017)
Table STEMCELL Technologies Embryonic Stem Cell Market Share (2012-2017)
Table Axol Bio Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Axol Bio Embryonic Stem Cell Production, Revenue, Price and Gross Margin (2012-2017)
Table Axol Bio Embryonic Stem Cell Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Embryonic Stem Cell
Figure Manufacturing Process Analysis of Embryonic Stem Cell
Figure Embryonic Stem Cell Industrial Chain Analysis
Table Raw Materials Sources of Embryonic Stem Cell Major Manufacturers in 2015
Table Major Buyers of Embryonic Stem Cell
Table Distributors/Traders List
Figure United States Embryonic Stem Cell Production and Growth Rate Forecast (2017-2021)
Figure United States Embryonic Stem Cell Revenue and Growth Rate Forecast (2017-2021)
Table United States Embryonic Stem Cell Production Forecast by Type (2017-2021)
Table United States Embryonic Stem Cell Consumption Forecast by Application (2017-2021)


More Publications